Biocryst Pharmaceuticals, Inc. · NASDAQ:BCRX
Biocryst Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 308 institutions reported holding Biocryst Pharmaceuticals, Inc. Largest: Vanguard, BlackRock and Ra Capital Management, L.P. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Biocryst Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 24.6M | +211K | Aug 13, 2026 | |
| BlackRock | 23.9M | +1.24M | Aug 7, 2026 | |
| Ra Capital Management, L.P. | 15.8M | no change | Aug 14, 2026 | |
| State Street | 15.2M | +2.98M | Aug 7, 2026 | |
| Deerfield Management Company, L.P. | 15.1M | +58,403 | Aug 14, 2026 | |
| TCG Crossover Management, LLC | 11M | no change | Aug 14, 2026 | |
| Perceptive Advisors LLC | 10.3M | +2.87M | Aug 14, 2026 | |
| Jupiter Topco LLC | 9.54M | first report | Aug 14, 2026 | |
| Vestal Point Capital, LP | 8.3M | +1.27M | Aug 14, 2026 | |
| Two Sigma | 6.78M | +383K | Aug 14, 2026 |